ArticleNature communications2024

Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.

Perla Pucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.